Why Are More Non-Smokers Getting Lung Cancer?



Español

At 37, Samantha Murrell was the picture of health. She hiked daily and enjoyed other outdoor activities like paddleboarding and mountain biking near her home in Montana.

Murrell was also proactive with her health and stayed on top of preventive exams. She diligently checked for moles that could indicate the beginnings of skin cancer, did breast self-exams because of a family history of breast cancer and stayed current with OB-GYN appointments to catch any early signs of reproductive cancers.

In early 2024, Murrell took a trip to India and battled a slight cough and chest pressure when she returned. Although she continued her daily activities, the chest pressure grew uncomfortable after two weeks, and she went to an urgent care clinic for treatment.

An X-ray showed her left lung had collapsed and was full of fluid. She was told to go to the emergency room immediately. After the fluid was drained and tested while she was hospitalized, the results came back as stage 4 lung cancer.

“I was so taken aback when they said I had lung cancer,” Murrell said. “It was the most confusing thing because I’d never been educated that non-smokers could get lung cancer. If I’d been told I had breast, cervical or skin cancer, I would have probably accepted it right away and said, ‘Okay let’s do this,’ but I thought this was the one cancer I just could not get because I didn’t smoke.”

Read: Women Who Have Never Smoked Can Get Lung Cancer >>

What’s causing lung cancer in non-smokers?

While smoking remains the leading risk factor for lung cancer, diagnoses like Murrell’s are becoming more common in non-smokers. Up to 2 out of 10 lung cancers (20,000-40,000 per year) are being diagnosed in people who never smoked or smoked fewer than 100 cigarettes in their lives. Lung cancer is also more likely to occur in people over 65, with 70 being the average age of diagnosis, but younger women are now being diagnosed with lung cancer at higher rates than their male counterparts — especially among non-smokers.

Norman Edelman, M.D., a professor of medicine at Stony Brook University who studies pulmonary diseases, said the answers aren’t clear on why lung cancer rates are increasing among non-smokers, but those exposed to particle pollution face the highest risk.

“Environmental pollutants increase the risk of lung cancer likely the same way as cigarettes, as oxidant chemicals disrupt the cells’ DNA,” Edelman said. “Although research is limited to pollutants which are monitored, fine particles are the most studied and the most implicated.”

While secondhand smoke — exposure to other people’s smoking — can be a factor in lung cancer development, environmental factors such as radon, air pollution, smoke from wildfires and fine particulate matter are increasingly being connected to cases in non-smokers. The Environmental Protection Agency says radon — radioactive gas that seeps into homes — is the top cause of lung cancer in non-smokers, contributing to about 2,900 lung cancer deaths in non-smokers each year.

More research is also connecting genetic factors to lung cancer development, with studies showing how air pollution triggers lung cancer development in cells with certain genetic mutations. While Murrell’s short trip to India likely didn’t cause her lung cancer, she believes the change in air quality and a weakened immune system from the trip triggered the symptoms that led to her diagnosis.

Continuing research into genetic mutations could provide more insight on links between pollution and lung cancer in non-smokers. Murrell said she has the HER2 mutation, which is most common in people with breast cancer, although up to 2% of lung cancer patients have the HER2 mutation. More common cell mutations in lung cancer patients are ALK or EGFR.

Read: Understanding the Different Types of Lung Cancer >>

When Murrell was in the hospital for her initial treatment, she tried to figure out the cause of her cancer. She remembers filling out a questionnaire asking if she’d worked in a factory or lived in an area with high pollution or coal mining — none of which applied. She lived in Iowa for seven years, and read that Iowa had the fastest growing rate of new cancers in the U.S. Could she have been exposed to agricultural-related pollutants years ago?

“I don’t have an answer for my case particularly,” Murrell said. “I was never around secondhand smoke. I was not in a hazardous job. I don’t think I was exposed to radon since I moved a lot and only lived in the same house for about two years my entire life. I just don’t know.”

Reducing your risk of lung cancer

While anyone can develop lung cancer, people of color — especially women — have worse outcomes from the disease, often because they’re less likely to get an early diagnosis or receive treatment, according to the American Lung Association. This is the case even when they’re experiencing common lung cancer symptoms like a worsening cough, chest pain, shortness of breath, wheezing, coughing up blood and fatigue.

Murrell encourages anyone experiencing those symptoms to see a healthcare provider immediately, although she’s aware of multiple survivors who went years being misdiagnosed. By the time they received a diagnosis, they were at stage 4.

“If you have those symptoms and they’re not going away with just normal treatments, be really persistent and push for more investigation,” she said.

Read: Doctors Shrugged Off My Cough Because I Wasn’t a Smoker — but I Had Stage 4 Lung Cancer >>

Edelman also encourages those eligible to be screened for lung cancer. “CAT scan screening has been successful. Over the past decades, the five-year survival rate from lung cancer has increased,” he said.

To be eligible for annual screening under current U.S. Preventive Services Task Force guidelines, you must be between the ages of 50 and 80, currently smoke or have quit within the past 15 years, and must have a 20 pack-year smoking history. (A pack year is the equivalent of smoking a pack [20 cigarettes] a day, every day for a year. A person could have a 20-pack year history by smoking a pack a day for 20 years or smoking two packs a day for 10 years ). These criteria, however, can leave out a large number of people without risk factors.

Murrell knows of younger women with a family history who were turned down for screening, and she notes how she didn’t have any of the typical lung cancer symptoms that would have led to a provider suggesting a screening. The only early sign she recognizes now was a blood clot in 2023 that HCPs said could be related to birth control use or sitting for long periods of time on another airplane trip. She believes now the clot was likely an early sign of lung cancer.

Today, Murrell and her husband are living in Park City, Utah, where she can be closer to an NCI-Designated Cancer Center for treatment. She calls her life “pretty normal” despite her diagnosis, and she still hikes four miles a day, lifts weights and works full time. She attributes her good health to her lifestyle before her cancer treatment and is thankful she’s able to continue doing the things she enjoys.

She’s also become an advocate with the Young Lung Cancer Initiative, which she found as a source of support while undergoing treatment. On their website and social media, she read multiple stories of people doing well years after a stage 4 diagnosis.

“The Young Lung Cancer Initiative really stood out to me,” she said. “Initially upon my diagnosis at my local hospital, I was given nine months to live, but seeing people’s messages gave me a lot of hope for this journey. I’m so fortunate I found the group so early on.”

This educational resource was created with support from Daiichi Sankyo.

From Your Site Articles

Related Articles Around the Web



Source link

Reducing Stigma About Lung Cancer



Slide 1

Support, Not Stigma

How to raise awareness and reduce stigma about lung cancer

Slide 2

The deadliest cancer

Each year, lung cancer takes more lives than any other kind of cancer in the U.S. It’s the second most common cancer in women and has one of the lowest survival rates.

But it lacks awareness, funding and support.

Why does lung cancer get so little attention?

Slide 3

Stigma keeps lung cancer from getting the attention it deserves.

Stigma is like a negative review. It may not be accurate, but it can influence how people think, feel and react.

Stigma around lung cancer leads to:

Fear

Guilt

Shame

Blame

Worse health outcomes

Less social support

More illness-related distress

Slide 4

The cost of stigma

If you have lung cancer, you may face more than just the disease.

You may receive negative reactions, judgment or a lack of empathy from loved ones, strangers and even healthcare providers.

No one deserves cancer, but people with lung cancer are often made to feel like they do.

Slide 5

Know the risk factors

While smoking is the biggest risk factor, it’s not the only one. Other risk factors for lung cancer include:

Family history

Air pollution

Exposure to radon, asbestos or secondhand smoke

Lung cancer can affect anyone.

Slide 6

Smoking and stigma

People who have lung cancer are often asked, “Did you smoke?” But we don’t ask questions like this about most other cancers.

It doesn’t matter why someone has cancer. No one deserves to get it.

If this question comes up, share that it’s hurtful.

Slide 7

Respond to stigma

When you tell people you have lung cancer, they may react with questions or statements that suggest it’s your fault.

If they do this, bring attention back to what matters: what you want them to know and how they can offer support.

Slide 8

Don’t let stigma keep you from treatment

Lung cancer is serious, but catching it early can lead to the best outcomes.

If you ever smoked or are having symptoms, don’t let stigma, embarrassment or fear keep you from getting screened — because screening saves lives.

Slide 9

Share stories

Stigma keeps you from thinking of a person with lung cancer as a mother, father, son, daughter or friend.

You can help fight stigma by sharing personal stories and experiences to put a human face on lung cancer.

Slide 10

How can we end stigma?

Raising awareness, educating people, and increasing empathy can help stop stigma and change the public’s view of lung cancer.

This educational resource was created with support from Daiichi Sankyo and Merck.



Source link

Reducir el estigma del cáncer pulmonar



Apoyo, no estigma

Cómo promover la concientización y reducir el estigma del cáncer pulmonar

Slide 2

El cáncer más letal

Cada año, el cáncer pulmonar toma más vidas que cualquier otro tipo de cáncer en EE.UU. Es el segundo cáncer más común para las mujeres y tiene una de las menores tasas de supervivencia.

Pero no hay concientización, fondos ni apoyo.

¿Por qué el cáncer pulmonar recibe tan poca atención?

Slide 3

El estigma evita que el cáncer pulmonar reciba la atención que merece.

El estigma es algo parecido a una evaluación negativa. Puede que no sea precisa, pero ejerce influencia en las opiniones, sentimientos y reacciones de la gente.

El estigma relacionado con el cáncer pulmonar causa:

Miedo

Culpa

Vergüenza

Reproches

Peores desenlaces clínicos

Menos apoyo social

Más angustia relacionada con la enfermedad

Slide 4

El costo del estigma

Si tienes cáncer pulmonar, podrías tener que enfrentar más que solo la enfermedad.

Podrías estar expuesta a opiniones o reacciones negativas o a una falta de empatía de seres queridos, extraños e incluso proveedores de atención médica.

Nadie merece tener cáncer, pero a menudo personas hacen sentir a pacientes con cáncer pulmonar que ellos sí.

Slide 5

Conoce los factores de riesgo

Aunque fumar es el factor de riesgo más importante, no es el único. Otros factores de riesgo de cáncer pulmonar incluyen:

Antecedentes familiares

Contaminación del aire

Exposición a radón, asbestos o a tabaquismo pasivo

El cáncer pulmonar puede afectar a cualquier persona.

Slide 6

Fumar y el estigma

Las personas que tienen cáncer pulmonar frecuentemente escuchan la pregunta, “¿fumaste?” Pero no hacemos preguntas como esta con otros tipos de cáncer.

No importa la razón por la cual alguien tiene cáncer. Nadie merece tenerlo.

Si escuchas esta pregunta, indica que esa pregunta es dolorosa.

Slide 7

Responde al estigma

Cuando digas a personas que tienes cáncer pulmonar, podrían reaccionar con preguntas o declaraciones que sugieren que es tu culpa.

Si hacen eso, enfoca la atención otra vez a lo que es importante: lo que quieres que sepan y cómo pueden apoyarte.

Slide 8

No dejes que el estigma evite que recibas tratamiento

El cáncer pulmonar es grave, pero detectarlo pronto puede hacer que tengas mejores desenlaces clínicos.

Si fumaste o estás teniendo síntomas, no dejes que el estigma, la vergüenza o el temor eviten que te examinen porque las examinaciones salvan vidas.

Slide 9

Comparte historias

El estigma evita que se considere que una persona con cáncer pulmonar es la madre, el padre, el hijo o el amigo de alguien.

Puede ser útil para combatir el estigma compartir historias y experiencias personales para poner un rostro humano en el cáncer pulmonar.

Slide 10

¿Cómo podemos terminar con el estigma?

Promover la concientización, educar a la gente y promover la empatía pueden ser medidas útiles para terminar con el estigma y para cambiar la opinión del público en general acerca del cáncer pulmonar.

Este recurso educativo se preparó con el apoyo de Daiichi Sankyo y Merck.



Source link

The Great Girlfriends Podcast: What Every Woman Needs to Know About Lung Cancer



We partnered with The Great Girlfriends Show to answer some of some common questions about lung cancer.

Our expert guest, Loretta Erhunmwunsee, M.D., shares:

  • Who is most at risk for lung cancer
  • Who should get screened for lung cancer and why
  • Non-smokers: how do you protect yourself from lung cancer?
  • The environmental impacts that increase the rates of lung cancer diagnosis in black and brown communities
  • How insurance coverage affects screenings and treatments

Listen to the podcast here.

This educational resource was created with support from Daiichi Sankyo and Merck.




Source link

Racial Disparities in Lung Cancer Screening



Ayanay Ferguson knew something just wasn’t right with her body when she returned from vacation with her husband in April 2021.

“I had swollen ankles and shortness of breath,” recalled Ferguson, 50, an Atlanta-area clinical psychologist.

She initially thought her symptoms were from post-vacation fatigue and her weight. As her symptoms lingered, she booked a telehealth appointment with a doctor, who advised her to get her heart checked. An EKG in an emergency room at a nearby hospital came back normal, but a medical resident was concerned enough about some of her lab work results to look into it further.

“He said he had just read an article about how that particular blood test did not elevate in African Americans, when there was, in fact, an issue, and that’s what kept him looking for stuff,” remembered Ferguson. “That’s why he ordered a CT chest scan.”

The CT scan showed what was later found to be a cancerous mass in her right lung. The diagnosis: stage 3Anon-small cell adenocarcinoma. “I had cancer cells in some of my lymph nodes,” she says.

Read: Understanding the Different Types of Lung Cancer >>

The lung cancer diagnosis was a shock for Ferguson, who’d never been a cigarette smoker and did not have a family history of the disease, but she agreed to the aggressive treatment plan her thoracic surgeon ordered. The plan was for her to have surgery to remove the mass and four rounds of chemotherapy. Three years later, Fergurson proudly reports being cancer-free.

A growing body of research reveals that, as a Black person, she is especially lucky to have beaten the disease that kills more than 125,000 Americans a year — more than breast, colon and prostate cancers combined. Lung cancer is more difficult to treat in its advanced stages, so early detection through screening greatly increases a person’s chance of survival. Yet racial disparities exist.

Studies have found that Black lung cancer patients were 15% less likely than white patients to be diagnosed early and they had the lowest five-year survival rate of any racial group. Black Americans tended to develop lung cancer at higher rates and at younger ages than their white counterparts, despite smoking fewer cigarettes on average. According to the American Lung Association, the disease claimed the lives of more than 14,000 Black Americans in 2021, the most recent year for available data.

Addressing persistent disparities in lung cancer early diagnosis and survival rates is central to the work being carried out by Melinda Aldrich, M.D., an associate professor at Vanderbilt University Medical Center. The groundbreaking 2019 study she co-authored with five colleagues found that screening eligibility guidelines exclude Black smokers more than other people of other races. The healthcare industry has been slow to respond to the growing push to change that, including medical insurance companies that determine what is considered preventive care and covered at low or no cost.

Aldrich’s research found that the U.S. Preventive Services Task Force (USPSTF), the government group that sets screening guidelines, required that a person had to be between 55 and 80 years old and have smoked the equivalent of a pack a day for 30 years to qualify for a life-saving early detection screening known as a low-dose CT scan. In addition to these criteria, a person needs to be either a current or former smoker, and former smokers need to have quit within the prior 15 years. Aldrich’s analysis of more than 84,000 adult smokers revealed that under that criteria, Black patients at relatively high risk of lung cancer were being disproportionately excluded from the eligible screening pool. More than 2 out of 3 Black smokers who were diagnosed with lung cancer did not meet the age and smoking history criteria at the time of their diagnosis.

“Based on those guidelines, we saw that of people who were diagnosed with lung cancer, 68% of African American individuals … would not have been eligible for lung cancer screening. And this is in contrast to 44% of white Americans who would not be eligible,” she said. “So, [there are] strong racial disparities in terms of eligibility and who’s able to get in the door to be screened.”

The work of Aldrich and her co-authors was cited in a 2021 decision by the USPSTF to make two changes that have nearly doubled the number of people eligible for lung cancer screening — lowering the age from 55 to 50 and reducing the number of smoking history pack years from 30 to 20.

“They didn’t do exactly what we proposed: something that might be considered controversial, which is making a race-specific change in the guidelines,” she said. “They made the guideline changes for everyone. So, actually, the disparities remain. They just made more people eligible.”

Aldrich said raising awareness about the screening test that has been widely available for well over a decade now is critical to helping improve outcomes and survival rates for lung cancer patients, especially Black patients. Still, she said, the medical industry needs to answer the call to go a step further to allow more people to qualify for early screening based on additional risk factors, such as race and ethnicity and family history. “If you have a history of smoking, talk to your doctor about whether you’re eligible for lung screening,” advised Aldrich. “We also need to remove the stigma associated with smoking; we should unite the community rather than associating blame.”

Ferguson said that although race-specific screening guideline changes most likely would not have helped in her case as a nonsmoker, she supports the shift to expand screening eligibility. “I don’t care if you are 30 or 70. If you smoked every day for 10 years or more, you should be able to say to your doctor, ‘I want a lung cancer screening’ and get it,” she said. “It’s money spent on the front end and money saved on the back end. And more importantly, it’s going to save more lives.”

This educational resource was created with support from Merck.

From Your Site Articles

Related Articles Around the Web



Source link

Desigualdades raciales en las examinaciones de cáncer de pulmón



Ayanay Ferguson sabía que algo no estaba bien con su cuerpo cuando regresó de vacaciones con su esposo en abril de 2021.

“Mis tobillos estaban hinchados y tenía dificultades para respirar”, recuerda Ferguson, de 50 años, una psicóloga clínica del área de Atlanta.

Inicialmente pensó que sus síntomas eran fatiga causada por las vacaciones y su peso. Puesto que sus síntomas persistieron, programó una consulta de telesalud con un doctor que le recomendó que haga que evalúen su corazón. Un ECG en una sala de emergencias en un hospital cercano mostró resultados normales, pero un residente médico tenía preocupaciones acerca de algunos resultados de sus pruebas de sangre y recomendó evaluaciones adicionales.

“Dijo que acababa de leer un artículo acerca de cómo esa prueba de sangre específica no mostraba resultados anormales para afroamericanos, cuando había en realidad un problema y eso fue lo que le motivó a seguir haciendo evaluaciones”, recuerda Ferguson. “Por eso solicitó una TC del pecho”.

La TC mostró algo que después se descubrió que era una masa cancerosa en su pulmón derecho. El diagnóstico:Adenocarcinoma no microcítico de etapa 3A. “Tenía células cancerosas en algunos de mis ganglios linfáticos”, dijo.

Lee: Entender los varios tipos de cáncer de pulmón >>

El diagnóstico de cáncer de pulmón fue una sorpresa para Ferguson que nunca había fumado cigarrillos ni tenía antecedentes familiares del trastorno, pero estuvo de acuerdo con el plan agresivo de tratamiento que solicitó su cirujano torácico. El plan consistía en la remoción de la masa con una cirugía y cuatro rondas de quimioterapia. Tres años después, Fergurson con orgullo reporta no tener cáncer.

Cada vez más investigaciones revelan que, al ser una persona de raza negra, es especialmente afortunada por haber vencido a ese trastorno que mata a más de 125,000 estadounidenses al año, más que los cánceres de mama, colon y próstata en conjunto. El cáncer de pulmón es más difícil de tratar en etapas avanzadas, así que una detección temprana a través de examinaciones mejora en forma importante las probabilidades de supervivencia de una persona. Sin embargo, existen desigualdades raciales.

Estudios demuestran que pacientes de cáncer de pulmón de raza negra tienen un 15% menos probabilidades que pacientes de raza blanca de recibir diagnósticos tempranos y tienen la menor tasa de supervivencia a cinco años que cualquier otro grupo racial. Los estadounidenses de raza negra tienden a desarrollar cáncer de pulmón a mayores tasas y a menores edades que sus contrapartes de raza blanca, a pesar de fumar menos cigarrillos en promedio. Según la American Lung Association [Asociación estadounidense del pulmón], el trastorno tomó las vidas de más de 14,000 estadounidenses de raza negra en 2021, el año más reciente para el cual hay datos disponibles.

Abordar las desigualdades persistentes de diagnósticos tempranos y de tasas de supervivencia de cáncer de pulmón es el tema central del trabajo realizado por Melinda Aldrich, M.D., una profesora adjunta del Vanderbilt University Medical Center [Centro médico de la universidad Vanderbilt]. El revolucionario estudio de 2019 que realizó en colaboración con cinco colegas determinó que las pautas de elegibilidad de las examinaciones excluyen a fumadores de raza negra más que a otras personas de otras razas. La industria de la atención de la salud ha reaccionado con lentitud a la presión cada vez mayor para cambiar eso, incluyendo las compañías de seguros médicos que determinan qué se considera atención preventiva con cobertura a un costo reducido o en forma gratuita.

La investigación de Aldrich demostró que el Equipo de trabajo de servicios preventivos de EE.UU. (USPSTF, por sus siglas en inglés), el grupo gubernamental que establece las pautas de las examinaciones, requería que una persona tenga entre 55 y 80 años y haya fumado el equivalente a un paquete al día durante 30 años para ser elegible para una examinación vital de detección temprana conocida como TC de dosis bajas. Además de esos criterios, una persona debe ser fumadora o exfumadora y las personas exfumadoras deben haber dejado de fumar hace 15 años o menos. El análisis de Aldrich de más de 84,000 fumadores adultos reveló que bajo esos criterios, los pacientes de raza negra que tienen un riesgo relativamente alto de cáncer de pulmón estaban siendo excluidos desproporcionadamente del grupo elegible para examinaciones. Más de 2 de cada 3 fumadores de raza negra que recibieron diagnósticos de cáncer de pulmón no cumplían con los criterios de edad y de antecedentes de consumo de cigarrillos cuando recibieron su diagnóstico.

“En función de esas pautas, vimos que de las personas que recibieron diagnósticos de cáncer de pulmón, el 68% de personas afroamericanas … no cumplían con los requisitos para las examinaciones de cáncer de pulmón. Y esto contrasta con el 44% de estadounidenses de raza blanca que tampoco serían elegibles”, dijo. “Así que, [hay] desigualdades raciales importantes en términos de la elegibilidad y de quien tiene acceso a las examinaciones”.

El trabajo de Aldrich y sus colegas que escribieron el estudio se mencionó en una decisión de 2021 del USPSTF por el cual se implementaron dos cambios que casi duplicaron el número de personas elegibles para examinaciones de cáncer de pulmón, al reducir la edad de 55 a 50 años y al reducir el número de años-cajetilla de 30 a 20 en lo que se refiere a los antecedentes de consumo de cigarrillos.

“No hicieron exactamente lo que propusimos: algo que se puede considerar controversial, es decir, hacer un cambio para una raza específica en las pautas”, dijo. “Hicieron los cambios de la pauta para todos. Así que, de hecho, las desigualdades siguen existiendo. Simplemente hicieron que más personas sean elegibles”.

Aldrich dijo que concientizar acerca de las examinaciones que han estado ampliamente disponibles por más de una década es crítico para ayudar a mejorar los resultados y las tasas de supervivencia para pacientes de cáncer de pulmón, especialmente para pacientes de raza negra. A pesar de eso, dijo, la industria médica debe responder el llamado de dar otro paso para permitir que personas sean elegibles para examinaciones tempranas en función de factores de riesgo adicionales, tales como raza, etnicidad y antecedentes familiares. “Si tienes un historial de consumo de cigarrillos, habla con tu doctor acerca de tu elegibilidad para examinaciones pulmonares”, recomendó Aldrich. “También debemos remover el estigma asociado con el cigarrillo; deberíamos unir a la comunidad en vez de tratar de encontrar culpables”.

Ferguson dijo que aunque cambios de las pautas de examinaciones para su raza específica muy probablemente no lo hubiesen ayudado porque no es fumadora, apoya el cambio para incrementar la elegibilidad para las examinaciones. “No importa si tienes 30 o 70 años. Si fumaste todos los días durante 10 años o más, deberías poder decirle a tu doctor, ‘quiero una examinación de cáncer de pulmón’ y deberías obtenerla”, dijo. “Es dinero que se gasta en forma preventiva, pero que ahorra gastos mayores en tratamientos. Y más importante, eso salvará más vidas”.

Este recurso educativo se preparó con el apoyo de Merck.

From Your Site Articles

Related Articles Around the Web



Source link